Life expectancy after bariatric surgery or usual care in patients with or without baseline type 2 diabetes in Swedish Obese Subjects.

"Competing interests BC and CK are employed by AstraZeneca and hold stocks in the same company. No other conflict of interest relevant to this study was reported."

"Funding This project was supported by grants from the Swedish Research Council (2021-01496 and 2020-01303), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-965955, ALFGBG-965046, ALFGBG-966076), the Health & Medical Care Committee of the Region Västra Götaland (VGFOUREG-931560, VGFOUREG-941125), the Swedish Heart Lung Foundation (20210186), the Swedish Diabetes Foundation (2019-417), and the Adlerbert Research Foundation. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Open access funding provided by University of Gothenburg."

"Seven Swedish regional ethics review boards approved the study protocol, and written or oral informed consent was obtained from all patients. This study is registered at ClinicalTrials.gov (NCT01479452)."